BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders

  February 13, 2025

   · 

  5 min read
• Press Releases

  Opna Bio Receives Orphan Drug Designation for OPN-6602, an Oral EP300/CBP Bromodomain Inhibitor, for Multiple Myeloma

  February 13, 2025

   · 

  2 min read
• Press Releases

  Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19 February 2025

  February 13, 2025

   · 

  1 min read
• Press Releases

  Genmab Publishes 2024 Annual Report

  February 13, 2025

   · 

  9 min read
• Press Releases

  FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)

  February 13, 2025

   · 

  7 min read
• Press Releases

  Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

  February 13, 2025

   · 

  2 min read
• Press Releases

  U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  February 13, 2025

   · 

  17 min read
• Press Releases

  FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy

  February 13, 2025

   · 

  4 min read
• Press Releases

  Genmab Files Annual Report with the U.S. Securities and Exchange Commission

  February 13, 2025

   · 

  3 min read
• Press Releases

  Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting

  February 13, 2025

   · 

  4 min read